Tag Archives: Clinical trials

Change in F&A Rate for Clinical Trials Effective 4/1/2021

May 14, 2021

The below message was sent on behalf of Dr. Robert Nobles, Vice President for Research Administration: March 12, 2021 Dear Colleagues, I am writing to share the outcome of an extensive review of our clinical trial definition and Facilities and Administrative Rate (F&A) rate. Over several months, we organized a working group that included faculty, […]

Posted in ORA, OSP, RGC | Also tagged , , , , , , | Comments closed

TRANSITION OF NIH INCLUSION MANAGEMENT SYSTEM TO NEW HUMAN SUBJECTS SYSTEM (LIVE 6/8/18)

May 29, 2018

The National Institutes of Health has recently announced that it will replace the current Inclusion Management System (IMS) which is used to report the sex/gender, race, and ethnicity of participants in human subjects research studies. The new system will be the Human Subjects System (HSS). The HSS will consolidate human subjects and clinical trial information […]

Posted in Announcements, Compliance, eRA, NIH | Also tagged , , , , | Comments closed

New Requirements for ClinicalTrials.gov

September 28, 2017

  Click here to learn about the new requirements for ClinicalTrials.gov.  

Posted in Announcements, Compliance, F&A, NIH, OCR, ORA Spotlight | Also tagged , , , , , , | Comments closed

New Requirements for Clinical Trials

September 6, 2017

March 29 Memo Regarding New Requirements for ClinicalTrials.gov

Posted in Announcements | Also tagged , , | Leave a comment

New ClinicalTrials.gov FDA regulation and NIH policy

January 26, 2017

Written by: Jennifer Prozonic Office for Clinical Research  Changes and Impact of FDA Final Rule & NIH Policy for ClinicalTrials.gov In September of 2016, the U.S. Department of Health and Human Services issued a final rule expanding the scope of ClinicalTrials.gov and requiring additional registration and results reporting requirements to the existing Food and Drug […]

Posted in OCR | Also tagged , | Comments closed